The business of healthcare imaging servicing is an interesting niche part in the health care market as a whole. Most investors can tell two main players; Alliance Healthcare services (NYSE:AIQ) and Radnet (NASDAQ:RDNT). But there is an interesting third player out there that investors seem to have overlooked, Digirad Corporation (NASDAQ:DRAD). We found out that its insiders are buying intensively for months now, and that the company recently won an important trial. We think this turnaround play is grossly undervalued, offering serious upside potential, while its debt-free and cash-rich balance sheet keeps the downside risk limited.
Digirad provides diagnostic solutions in the science of imaging primarily in the United States. The company operates...
|FREE||SA PRO MEMBERS|
|IDEA GENERATOR||X||Exclusive access to 10 PRO ideas every day|
|INVESTING IDEAS LIBRARY||X||Exclusive access to PRO library of more than 15,000 ideas|
|SECTOR EXPERT NETWORK||X||Exclusive access to all sector experts for direct consultation|
|PERFORMANCE TRACKING||X||Track performance of all PRO stock ideas|
|PROFESSIONAL TOOLS||X||Professional Idea Filters to zero-in based on industry, market cap and more|